Kamakura, Japan

Mikito Hirakata



 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Mikito Hirakata: Innovator in Therapeutic Agents**

Introduction

Mikito Hirakata is a notable inventor based in Kamakura, Japan. He is recognized for his contributions to the field of therapeutics, particularly in developing agents aimed at treating cachexia. With a keen focus on innovation, Hirakata's work exemplifies the intersection of science and effective medical treatment.

Latest Patents

Hirakata holds a patent for a therapeutic or prophylactic agent for cachexia. This patent includes an effective ingredient characterized by a compound with a specified morphinan skeleton. The compound structure serves as a pharmacologically acceptable acid addition salt, which shows promise in the medical field for combating this condition.

Career Highlights

Hirakata is currently associated with Toray Industries, Inc., where his expertise contributes to groundbreaking research and development. His work not only showcases his inventive prowess but also highlights the ongoing efforts in the pharmaceutical industry to enhance therapeutic options for patients suffering from various ailments.

Collaborations

Throughout his career, Mikito Hirakata has collaborated with notable colleagues such as Tomohiko Suzuki and Yoshitaka Yoshizawa. These professional partnerships are essential in driving innovation and expanding research capabilities within Toray Industries, Inc.

Conclusion

Mikito Hirakata's contributions to the realm of pharmaceuticals, particularly with his patent for a therapeutic agent for cachexia, underscore the importance of innovation in addressing critical health issues. His work serves as an inspiration for future inventors and researchers in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…